Galleri fork article image credits 1. galleri-sensitivity-by-cancer.svg Original Empirical Health visualization of the 25 CCGA cancer-class point estimates in GRAIL's performance table: https://www.galleri.com/hcp/galleri-test-performance Study: Klein EA et al., Annals of Oncology, 2021. https://doi.org/10.1016/j.annonc.2021.05.806 This is not a reproduction of the study artwork. Dots show sensitivity point estimates. Lines are two-sided 95% Wilson score intervals calculated by Empirical from published detected/total counts in Figure 3 of the CCGA poster; they are not transcribed published intervals. Poster: https://grail.com/wp-content/uploads/2021/10/Klein.AAFP_FMX_2021.CCGA3_Poster.FINAL_.pdf These are not individual predictions or later-assay screening performance. Terracotta and asterisks indicate breast, cervical, colorectal and lung cancers with routine screening for eligible people. PSA is an individual decision, not highlighted. Desktop panels are side-by-side; mobile panels stack, each with the same 0–100% scale. Public versions: galleri-sensitivity-dots.svg and galleri-sensitivity-dots-mobile.svg. 2. galleri-pathfinder2-follow-up-figure2a.png Nabavizadeh et al., Performance and safety of a multi-cancer early detection test: the PATHFINDER 2 study. Nature Medicine, 2026. https://doi.org/10.1038/s41591-026-04618-w © The Author(s), licensed under CC BY 4.0: https://creativecommons.org/licenses/by/4.0/ Reused existing crop of Figure 2a. Figure content, colors and labels unchanged. Targeted diagnostic workup excludes diagnostic PET/CT and tests triggered by it after a negative targeted workup. Unresolved participants are included as false positives in this panel. Categories overlap and must not be summed. 3. cancer-blood-test-options.svg Original Empirical Health category diagram of five selected products, not an exhaustive market inventory or ranking. Availability checked October 29, 2026. Primary sources linked in the accompanying article. Shield's optional MCD report is distinct from the FDA-approved colorectal screening test.